Transmitted HIV Type 1 Drug Resistance in Newly Diagnosed Cuban Patients

AIDS Research and Human Retroviruses

Volumn 29, Issue 2, 2013, Pages 411-414

  Machado, Liuber Y ^a   Dubed, Marta ^a   Díaz, Héctor ^a   Ruiz, Nancy ^a   Romay, Dania ^a   Váldes, Neysi ^a   Blanco, Madeline ^a   Silva, Eladio ^a  

^a AIDS Research Laboratory   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84977555435     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0183     Document Type: Article

References (15)

1. Ribeiro RM and Bonhoeffer A: Production of resistant HIV mutants during antiretroviral therapy. Proc Natl Acad Sci USA 2000;97:7681-7686
2. Geretti AM: Epidemiology of antiretroviral drug resistance in drug naive persons. Curr Opin Infect Dis 2007;20:22-32
3. Gorry C: Cuban's National HIV/AIDS Program. Medic Review 2011;13(2):5-8
4. Ruibal I, Cuevas M.T., Dã­az H.M., Villahermosa M.L., Noa E, Parga E.V., et al.: Genotypic resistance mutations to antiretroviral drugs in HIV-1 B and non-B subtypes from Cuba. Rev Panam Salud Pãºblica 2001;10(3):174-180
5. Pã©rez L, Pã©rez Alvarez L, Carmona R, Aragonã©s C, Delgado E, Thomson M, et al.: Genotypic resistance to antiretroviral drug in patients infected with several HIV type I genetic forms in Cuba. AIDS Res Hum Retroviruses 2007;23 (3):407-414
6. Esteves A, Parreira R, and Venneno T: Molecular epidemiology of HIV type 1 infection in Portugal : High prevalence of non-B subtypes. AIDS Res Hum Retroviruses 2002;18:313-325
7. Quarleri J.F., Rubio A, Carobene M, Turk G, Vignoles M, Harrigan R.P., et al.: HIV type 1 BF recombinant strains exhibit different pol gene mosaic patterns: Descriptive analysis from 284 patients under treatment failure. AIDS Res Hum Retroviruses 2004;20(10):1100-1107
8. Kumar S, Tamura K, and Nei M: MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;5(2):150-163
9. Bennett D, Camacho R, Otelea D, Kuritzkes D, Fleury H, Kiuchi M, et al.: Drug resistance mutations for surveillance of transmitted HIV-1 drug resistance: 2009 update. PLoS one 2009;4(3):e4724
10. Little SJ: Transmission and prevalence of HIV resistance, among treatment naã¯ve subjects. Antiviral Ther 2000;5:33-40
11. Castro E, Khankarly M, Cuiffreda D, Bã¼rgisser P, Cavassini M, Yerly S, et al.: HIV-1 drug resistance transmission network in southwest Switzerland. AIDS Res Hum Retroviruses 2010;26(11):1233-1238
12. Little S, Frost S, Wong J.K., Smith S.M., Kosakovsky Pond S, Ignacio C, et al.: Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol 2008;82(11):5510-5518
13. Wensing A, van deVijver A, Angorano G, Asjo B, Balotta C, Bren E, et al.: Prevalence of drug resistance HIV-1 variants in untreated individuals in Europe: Implications for clinical management. J Infect Dis 2005;192:958-966
14. Vercauteren J, Derdelinckx I, Sasse A, Boguert M, Ceunen H, De Roo A, et al.: Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naã¯ve patients in Belgium from 2003 to 2006. AIDS Res Hum Retroviruses 2008;24(3):355-362
15. Machado L.Y., Blanco M, Dubed M, Dã­az H.M., Ruiz N.M., Vã¡ldes N, et al.: HIV type 1 genetic diversity in newly diagnosed Cuban patients. AIDS Res Hum Retroviruses 2012;28(8):956-960